Serum androgens as prognostic biomarkers in castration-resistant prostate cancer: results from an analysis of a randomized phase III trial. Academic Article uri icon

Overview

MeSH Major

  • Androgens
  • Androstadienes
  • Prednisone
  • Prostatic Neoplasms

abstract

  • SA, measured with a novel ultrasensitive assay in COU-AA-301, is prognostic for OS and may be useful for risk stratification in mCRPC clinical trials.

publication date

  • August 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5569674

Digital Object Identifier (DOI)

  • 10.1200/JCO.2012.45.4595

PubMed ID

  • 23816964

Additional Document Info

start page

  • 2791

end page

  • 8

volume

  • 31

number

  • 22